The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...

Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...

To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...

WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...

A fish and chip shop owner has credited a charity which has supported him for more than 20 years after receiving his HIV diagnosis with ...

MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).

Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...

To tackle HIV/AIDS in South Africa, China, through the China Global Development and South-South Cooperation Fund, has announced a two-year funding commitment of 3.49 million U.S. dollars.